488 related articles for article (PubMed ID: 25302769)
1. Circadian clock, cancer, and chemotherapy.
Sancar A; Lindsey-Boltz LA; Gaddameedhi S; Selby CP; Ye R; Chiou YY; Kemp MG; Hu J; Lee JH; Ozturk N
Biochemistry; 2015 Jan; 54(2):110-23. PubMed ID: 25302769
[TBL] [Abstract][Full Text] [Related]
2. Circadian clock, carcinogenesis, chronochemotherapy connections.
Yang Y; Lindsey-Boltz LA; Vaughn CM; Selby CP; Cao X; Liu Z; Hsu DS; Sancar A
J Biol Chem; 2021 Sep; 297(3):101068. PubMed ID: 34375638
[TBL] [Abstract][Full Text] [Related]
3. Clocks, cancer, and chronochemotherapy.
Sancar A; Van Gelder RN
Science; 2021 Jan; 371(6524):. PubMed ID: 33384351
[TBL] [Abstract][Full Text] [Related]
4. Circadian clock control of the cellular response to DNA damage.
Sancar A; Lindsey-Boltz LA; Kang TH; Reardon JT; Lee JH; Ozturk N
FEBS Lett; 2010 Jun; 584(12):2618-25. PubMed ID: 20227409
[TBL] [Abstract][Full Text] [Related]
5. Identification of Circadian Determinants of Cancer Chronotherapy through In Vitro Chronopharmacology and Mathematical Modeling.
Dulong S; Ballesta A; Okyar A; Lévi F
Mol Cancer Ther; 2015 Sep; 14(9):2154-64. PubMed ID: 26141947
[TBL] [Abstract][Full Text] [Related]
6. Chronotherapy and the molecular clock: Clinical implications in oncology.
Innominato PF; Lévi FA; Bjarnason GA
Adv Drug Deliv Rev; 2010 Jul; 62(9-10):979-1001. PubMed ID: 20600409
[TBL] [Abstract][Full Text] [Related]
7. Effect of circadian clock mutations on DNA damage response in mammalian cells.
Gaddameedhi S; Reardon JT; Ye R; Ozturk N; Sancar A
Cell Cycle; 2012 Sep; 11(18):3481-91. PubMed ID: 22918252
[TBL] [Abstract][Full Text] [Related]
8. It's About Time: Advances in Understanding the Circadian Regulation of DNA Damage and Repair in Carcinogenesis and Cancer Treatment Outcomes.
Ashok Kumar PV; Dakup PP; Sarkar S; Modasia JB; Motzner MS; Gaddameedhi S
Yale J Biol Med; 2019 Jun; 92(2):305-316. PubMed ID: 31249491
[TBL] [Abstract][Full Text] [Related]
9. Long-term, genome-wide kinetic analysis of the effect of the circadian clock and transcription on the repair of cisplatin-DNA adducts in the mouse liver.
Yang Y; Liu Z; Selby CP; Sancar A
J Biol Chem; 2019 Aug; 294(32):11960-11968. PubMed ID: 31217280
[TBL] [Abstract][Full Text] [Related]
10. Circadian Timekeeping in Anticancer Therapeutics: An Emerging Vista of Chronopharmacology Research.
Puppala A; Rankawat S; Ray S
Curr Drug Metab; 2021; 22(13):998-1008. PubMed ID: 34802402
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-DNA adduct repair of transcribed genes is controlled by two circadian programs in mouse tissues.
Yang Y; Adebali O; Wu G; Selby CP; Chiou YY; Rashid N; Hu J; Hogenesch JB; Sancar A
Proc Natl Acad Sci U S A; 2018 May; 115(21):E4777-E4785. PubMed ID: 29735688
[TBL] [Abstract][Full Text] [Related]
12. Circadian control of cisplatin-DNA adduct repair and apoptosis in culture cells.
Jeon J; Lee S; Park JM; Lee TH; Kang TH
Int J Biochem Cell Biol; 2023 Sep; 162():106454. PubMed ID: 37574041
[TBL] [Abstract][Full Text] [Related]
13. Molecular connections between circadian rhythm and genome maintenance pathways.
Kolinjivadi AM; Chong ST; Ngeow J
Endocr Relat Cancer; 2021 Feb; 28(2):R55-R66. PubMed ID: 33300498
[TBL] [Abstract][Full Text] [Related]
14. Circadian clock and cell cycle: Cancer and chronotherapy.
Yao J; He C; Zhao W; Hu N; Long D
Acta Histochem; 2021 Dec; 123(8):151816. PubMed ID: 34800857
[TBL] [Abstract][Full Text] [Related]
15. The mammalian clock and chronopharmacology.
Griffett K; Burris TP
Bioorg Med Chem Lett; 2013 Apr; 23(7):1929-34. PubMed ID: 23481644
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological modulators of the circadian clock as potential therapeutic drugs: focus on genotoxic/anticancer therapy.
Antoch MP; Kondratov RV
Handb Exp Pharmacol; 2013; (217):289-309. PubMed ID: 23604484
[TBL] [Abstract][Full Text] [Related]
17. Chronopharmacological strategies focused on chrono-drug discovery.
Ohdo S; Koyanagi S; Matsunaga N
Pharmacol Ther; 2019 Oct; 202():72-90. PubMed ID: 31173839
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of multidrug cancer chronotherapy based on cell cycle model under influences of circadian clock.
Inokawa H; Katayama N; Nakao M
Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():1439-1442. PubMed ID: 28268596
[TBL] [Abstract][Full Text] [Related]
19. The circadian timing system in clinical oncology.
Innominato PF; Roche VP; Palesh OG; Ulusakarya A; Spiegel D; Lévi FA
Ann Med; 2014 Jun; 46(4):191-207. PubMed ID: 24915535
[TBL] [Abstract][Full Text] [Related]
20. Circadian regulation of DNA excision repair: implications for chrono-chemotherapy.
Kang TH; Sancar A
Cell Cycle; 2009 Jun; 8(11):1665-7. PubMed ID: 19411851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
